Cargando…
COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264646/ https://www.ncbi.nlm.nih.gov/pubmed/32542209 http://dx.doi.org/10.1002/rth2.12350 |
| _version_ | 1783540992338558976 |
|---|---|
| author | Cannegieter, Suzanne C. Klok, Frederikus A. |
| author_facet | Cannegieter, Suzanne C. Klok, Frederikus A. |
| author_sort | Cannegieter, Suzanne C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7264646 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72646462020-06-02 COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Cannegieter, Suzanne C. Klok, Frederikus A. Res Pract Thromb Haemost Commentary John Wiley and Sons Inc. 2020-06-14 /pmc/articles/PMC7264646/ /pubmed/32542209 http://dx.doi.org/10.1002/rth2.12350 Text en © 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentary Cannegieter, Suzanne C. Klok, Frederikus A. COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title | COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title_full | COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title_fullStr | COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title_full_unstemmed | COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title_short | COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance |
| title_sort | covid‐19 associated coagulopathy and thromboembolic disease: commentary on an interim expert guidance |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264646/ https://www.ncbi.nlm.nih.gov/pubmed/32542209 http://dx.doi.org/10.1002/rth2.12350 |
| work_keys_str_mv | AT cannegietersuzannec covid19associatedcoagulopathyandthromboembolicdiseasecommentaryonaninterimexpertguidance AT klokfrederikusa covid19associatedcoagulopathyandthromboembolicdiseasecommentaryonaninterimexpertguidance |